May 07, 2020
Duchenne Muscular Dystrophy Market is Anticipated to Grow With a CAGR of 31.8% for the Study Period of 2017-2030: DelveInsight
Jan 13, 2020
PTC Therapeutics Provides Corporate Update and Highlights Pipeline Progress at 2020 J.P. Morgan Healthcare Conference
Jun 28, 2019
PTC Provides Update on Translarna(TM) (ataluren) Application for Label Expansion
Jun 07, 2019
PTC Therapeutics Receives FDA Approval for the Expansion of the EMFLAZA® (deflazacort) Labeling to Include Patients 2-5 Years of Age
Apr 29, 2019
Translarna(TM) (ataluren) is the First Therapy Approved in Brazil for Duchenne Muscular Dystrophy
Feb 28, 2019
PTC Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides a Corporate Update
Jan 17, 2019
Parent Project Muscular Dystrophy Publishes 10 Year Registry Report
Jan 07, 2019
PTC Therapeutics Provides Corporate Update and Outlines 5-year Strategic Plan at 2019 J.P. Morgan Healthcare Conference
Dec 18, 2018
PTC Therapeutics Deepens Financial and Commercial Expertise of Board with Two New Appointments
Nov 05, 2018
PTC Therapeutics Reports Third Quarter 2018 Financial Results and Provides a Corporate Update
Oct 15, 2018
DMD Drugs Market Size Worth $4.11 Billion by 2023 | CAGR: 41.3%: Grand View Research, Inc.
Aug 23, 2018
PTC Therapeutics Successfully Completes Acquisition of Agilis Biotherapeutics
Aug 07, 2018
PTC Therapeutics Reports Second Quarter 2018 Financial Results and Provides a Corporate Update
Jul 24, 2018
PTC Therapeutics Announces Publication of Data Demonstrating the Clinical Differentiated Benefit of Deflazacort
Jul 19, 2018
PTC Therapeutics to Acquire Agilis Biotherapeutics
Jul 09, 2018
PTC Therapeutics Announces Positive Data from its Translarna(TM) Phase II Clinical Trial in Children as Young as Two Years with Nonsense Mutation Duchenne Muscular Dystrophy
May 09, 2018
PTC Therapeutics Reports First Quarter 2018 Financial Results and Provides a Corporate Update
Jan 08, 2018
PTC Therapeutics Provides Corporate Update and Outlines 2018 Strategic Priorities
Jun 13, 2017
Hope for Gabe Foundation Races Across America to Bring Awareness to 11,599% Price Increase for Children's Drug